We're making headlines

We're on a mission to transform medical research, for good. And people are taking notice.

Nancy Ryerson

Nancy Ryerson is a digital communicator with years of experience covering healthcare. Today, she's a Digital Marketing Manager at Antidote, where she manages the company's content marketing and SEO strategies. Prior to joining Antidote, Nancy spent three years at The Michael J. Fox Foundation, where she created content for Parkinson's disease patients and expanded the Foundation's email list by 100,000+ members in two years through search and social strategies. She holds a BA in English and journalism from NYU.

Find me on:

Biotecnika: "Antidote Technologies Raises $11M In Funding Round Led By Merck, To Accelerate Development Of Its Trial Matching Platform"

LondonTechWatch: "These are the 15 London Startups That Raised the Most Capital in September 2017"

Biospectrum Asia: "Startup Antidote raises £11m"

Perficient: "How Merck & Facebook Are Pushing The Bounds Of Patient Recruitment"

MM&M: "How Pablo Graiver plans to solve the problem of clinical-trial recruitment"

Bloomberg News: "Drug tests draw from travel site to fix industry flaw"

Financial Times: "Shazam CFO jumps to drug research app TrialReach"

Forbes: "Drug Companies Pin Hopes On TrialReach To Enroll Patients In Clinical Trials Faster"

Techcrunch: "TrialReach Raises $13.5M Series B To Match Patients To Clinical Trials"

The Huffington Post: "TrialReach Chosen as One of London's Fastest Growing Health Tech Startups"

Press Contact
media-kit-cta